QQ客服 官方微博 反馈留言

	Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
	Dong, Hang; Yin, Hao; Zhao, Chunlong; Cao, Jiangying; Xu, Wenfang; Zhang, Yingjie
刊名	MOLECULES
	2019
卷号	24期号:13
关键词	HDAC EGFR multi-target inhibitor antitumor
DOI	10.3390/molecules24132407
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4545768
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Bio
推荐引用方式 GB/T 7714	Dong, Hang,Yin, Hao,Zhao, Chunlong,et al. Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors[J]. MOLECULES,2019,24(13).
APA	Dong, Hang,Yin, Hao,Zhao, Chunlong,Cao, Jiangying,Xu, Wenfang,&Zhang, Yingjie.(2019).Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors.MOLECULES,24(13).
MLA	Dong, Hang,et al."Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors".MOLECULES 24.13(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。